• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Relative risk of heart failure from traditional risk factors is greater in younger than in older adults

byCyrus AyubchaandTeddy Guo
April 23, 2021
in Cardiology, Chronic Disease
Reading Time: 3 mins read
Rilonacept may lower pericarditis recurrence in patients with relapsing pericarditis
Share on FacebookShare on Twitter

1. Hypertension, diabetes, smoking, atrial fibrillation, and previous myocardial infarction were associated with a higher risk of incident heart failure in younger adults (<55 years) compared to elderly participants (≥75 years).

2. There were no interactions between age and body-mass index or glomerular filtration rate with respect to the incidence of heart failure.

Evidence Rating Level: 2 (Good)

Study Rundown: Heart failure is one of the most prevalent causes of mortality in the United States. While the risk factors of heart failure are well characterized, the temporal relevance of such risk factors are not well understood. This study found that traditional risk factors, such as hypertension, diabetes, current smoking status, atrial fibrillation, and previous myocardial infarction, led to higher risks of heart failure in younger individuals as compared to elderly individuals. Though the higher absolute risk of heart failure in older populations has led to a greater emphasis on care in this population, these findings show potential value in directing some clinical focus to the alteration of modifiable risks in younger individuals. This study uses data from three large observational cohorts such that the study population is quite large and allows for a significant length of follow-up for the study cohort. Nevertheless, this study was observational in nature meaning the association between age, traditional risk factors, and incidence of heart failure remains correlational. Furthermore, heart failure was a relatively rare outcome in younger populations so the prevalence of such disease incidence may harm the certainty of risk estimations.

Click to read the study in the BMJ

Relevant Reading: Epidemiology and risk profile of heart failure

RELATED REPORTS

Chronic exposure to particulate matter is associated with increased cardiovascular risk

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

A medical care at home program following hospitalization with acute decompensated heart failure may offer a safe and effective alternative to continued hospitalization

In-Depth [retrospective cohort]: This study utilized three cohorts including the Framingham Heart Study (FHS, n=9877), the Prevention of Renal and Vascular Endstage Disease (PREVEND, n=8115) study, and the Multi-Ethnic Study of Atherosclerosis (MESA, n=6683) all of which included baseline examinations where all individuals were followed for at least 15 years. Survival and heart failure incidence was analyzed via Kaplan-Meier curves and further assessed via log-rank tests. Multivariable Cox models, accounting for several covariables (e.g. body mass index, sex, lipid levels, smoking status, atrial fibrillation), were used to derive mean hazard ratios with 95% confidence intervals as a means of examining the association of risk factors with incident heart failure.

Of the 24,675 individuals observed in this study, the median follow-up was approximately 13 years. In total, 138/11,599 (1%), 293/5,587 (5%), 538/5,190 (10%), and 412/2,299 (18%) of young (<55 years), middle aged (55-64 years), old (65-74 years), and elderly (≥75 years) individuals, respectively, developed heart failure. Hypertension (hazard ratio [HR]: 3.02 [2.10-4.34] in young vs. 2.19 [1.76-2.73] in elderly), diabetes (HR: 3.86 [2.39-6.23] in young vs. 1.98 [2.59-2.46] in elderly), current smoking (HR: 2.58 [1.83-3.63] in young vs. 1.43 [1.15-1.177] in elderly), atrial fibrillation (HR: 4.74 [1.44-15.6] in young vs. 2.31 [1.67-3.21] in elderly), and previous myocardial infarction (HR: 3.30 [1.77-6.14] in young vs. 2.92 [2.28-3.74] in elderly) all conferred a greater relative risk of heart failure incidence in younger adults compared to elderly participants. While absolute risk of heart failure was higher in elderly participants compared to younger (18% vs. 1%, respectively), the overall population attributable risk of heart failure due to traditional risk factors was higher in younger (75%) than elderly participants (53%).

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiologycongestive heart failureheart failurehfpefHFpEF (heart failure with preserved ejection fractionhfrefHFrEF (heart failure with reduced ejection fraction)risk factors
Previous Post

#VisualAbstract Ivosidenib or enasidenib combined with intensive chemotherapy were well-tolerated and showed encouraging clinical activity in newly diagnosed mIDH1/mIDH2 acute myeloid leukemia

Next Post

Hospitalizations for pediatric abusive head trauma decline during the COVID-19 pandemic

RelatedReports

Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Cardiology

A medical care at home program following hospitalization with acute decompensated heart failure may offer a safe and effective alternative to continued hospitalization

July 24, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

Catheter ablation within 1 year of atrial fibrillation diagnosis is associated with reduced risk of recurrence

July 24, 2026
Next Post
Abusive head trauma results in fewer productive life-years

Hospitalizations for pediatric abusive head trauma decline during the COVID-19 pandemic

2 Minute Medicine Rewind April 26, 2021

Neonatal neuroimaging with strong negative predictive value for developmental outcomes: The NEURO study

Epidemiological and virological characteristics of respiratory tract infections in children during COVID-19 outbreak

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.